O
Oftalmologia Global | Rosario, Argentina
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Sirolimus
DE-109
Axitinib
Vamikibart
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 3 total trials
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration
Active, not recruiting
Neovascular Age-Related Macular Degeneration
Drug: OTX-TKI (axitinib implant)
Drug: Aflibercept
This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.
Active, not recruiting
Uveitic Macular Edema
Other: Sham
Drug: Vamikibart
Trial sponsors
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems